Predictive Technology (CE) Stock Price

0.00 (0.0%)
Volume 0.00
Bid Price
Ask Price
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
Predictive Technology Group Inc (CE) PRED OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.0007 20:00:00
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
0 0.00 - 0.0001 - 0.2499
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.0007 USD


Draw Mode:

Predictive Technology Group Inc (CE) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 217.97k 311.39M 35.64M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
11.60k $ - - - -

more financials information »

Predictive Technology (CE) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PRED Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.00070.00070.00070.00072,7500.000.0%
1 Month0.00030.00070.00030.00050721,6660.0004133.33%
3 Months0.00210.00350.00010.001045957,000-0.0014-66.67%
6 Months0.00510.04590.00010.00210837,514-0.0044-86.27%
1 Year0.13730.24990.00010.0912147222,316-0.1366-99.49%
3 Years2.512.590.00010.617267349,670-2.51-99.97%
5 Years0.910756.910.00011.12290,068-0.91005-99.92%

Predictive Technology (CE) Description

Predictive Technology Group, Inc. (Stock Symbol: PRED), a Salt Lake City, UT therapeutics and life sciences company, is a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through unique novel gene-based diagnostics, biotechnology treatments and companion therapeutics. Through its' wholly-owned subsidiaries, Predictive Therapeutics and Predictive Biotech, the company focuses on four main clinical categories: Endometriosis, Scoliosis, Degenerative Disc Disease and Regenerative Human Cell and Tissue Products. In addition to Predictive Biotech's efforts to advance regenerative medicine, Predictive Therapeutics is committed to assisting women in overcoming the devastating consequences of endometriosis via appropriate early-stage diagnosis and subsequent treatment.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now